centerforbiosimilars10h
BioRationality: Biosimilar Associations and Stakeholders Representing Biosimilars
Sarfaraz K. Niazi, PhD, dives into the role that biosimilar associations and organizations play in promoting biosimilars as ...
centerforbiosimilars1d
FTC Releases Second Report on PBMs Meddling in Generic Drug Markets
The 3 largest pharmacy benefit managers (PBMs) increased many specialty generic drugs prices by hundreds of percent, with ...
centerforbiosimilars3d
Functional Similarity Between Ustekinumab Biosimilar ABP 654, Stelara in Crohn Disease
Functional similarity of the ustekinumab biosimilar ABP 654 (Wezlana) and the reference product (Stelara) was confirmed by a series of in vitro studies, which support the totality of evidence for the ...
centerforbiosimilars3d
Mayuri Mathuria, MBA
The Top 5 Biosimilar Articles for the Week of December 2 ...
centerforbiosimilars3d
Christina Corridon, MPH, MBA
The Top 5 Biosimilar Articles for the Week of December 2 ...
centerforbiosimilars3d
Prateek Yadav, MPTh, MBA
The Top 5 Biosimilar Articles for the Week of December 2 ...
centerforbiosimilars3d
Adrian Goh, MEc
The Top 5 Biosimilar Articles for the Week of December 2 ...
centerforbiosimilars3d
Rosalind Wong, PharmD Candidate
The Top 5 Biosimilar Articles for the Week of December 2 ...
centerforbiosimilars3d
Paul Cornes, BM, BCH, MA, MRCP, FRCR
The Top 5 Biosimilar Articles for the Week of December 2 ...
centerforbiosimilars3d
The Top 5 Biosimilar Articles for the Week of January 13
Number 4: Celltrion’s denosumab biosimilar demonstrated equivalent efficacy, safety, and immunogenicity compared with the originator in a phase 3 trial involving postmenopausal women with osteoporosis ...